Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Nutex Health (NUTX) Equity Average (2016 - 2025)

Historic Equity Average for Nutex Health (NUTX) over the last 15 years, with Q3 2025 value amounting to $387.5 million.

  • Nutex Health's Equity Average rose 37892.94% to $387.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $387.5 million, marking a year-over-year increase of 37892.94%. This contributed to the annual value of $133.8 million for FY2024, which is 3419.97% up from last year.
  • As of Q3 2025, Nutex Health's Equity Average stood at $387.5 million, which was up 37892.94% from $296.1 million recorded in Q2 2025.
  • Nutex Health's 5-year Equity Average high stood at $387.5 million for Q3 2025, and its period low was $32.6 million during Q1 2021.
  • Over the past 5 years, Nutex Health's median Equity Average value was $126.4 million (recorded in 2022), while the average stood at $161.2 million.
  • As far as peak fluctuations go, Nutex Health's Equity Average surged by 944065.48% in 2021, and later crashed by 6904.91% in 2023.
  • Nutex Health's Equity Average (Quarter) stood at $202.4 million in 2021, then plummeted by 37.54% to $126.4 million in 2022, then decreased by 27.23% to $92.0 million in 2023, then soared by 45.81% to $134.2 million in 2024, then soared by 188.81% to $387.5 million in 2025.
  • Its Equity Average stands at $387.5 million for Q3 2025, versus $296.1 million for Q2 2025 and $221.9 million for Q1 2025.